Earnings Call
May 7, 2026
Q1 FY2026
EPS Estimate
1.96
EPS Actual
2.06
Post-Earnings Close
$181.68
Earnings Reaction
-0.0%
Charles River Laboratories posted first quarter 2026 results that came in line to slightly ahead of its own prior outlook, with revenue of $996 million representing 1.2% reported growth but a 1.5% organic decline, and non-GAAP EPS of $2.06, a 12% year-over-year decline but better than the high-teens decline the company had guided. The quarter was deliberately framed as a trough: management identified several discrete, non-recurring headwinds, elevated stock compensation tied to the CEO transition, NHP study-related costs in DSA, and timing-driven weakness in NHP shipments within RMS, that collectively compressed the non-GAAP operating margin by 280 basis points to 16.3%. With those headwinds expected to subside and the benefit of completed portfolio actions beginning to flow through, the company guided for at least 30% sequential EPS growth in Q2 and a second-half operating margin more than 500 basis points above the first half, with over half of that improvement attributable to acquisitions and divestitures.
Report generated on May 9, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full CRL analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.